151 – 160 of 457
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
PSA is Dead, Long Live PSA
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Evaluating the PCPT risk calculator in ten international biopsy cohorts : Results from the Prostate Biopsy Collaborative Group
(
- Contribution to journal › Article
-
Mark
Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators : Results from the prostate biopsy collaborative group
(
- Contribution to journal › Article
-
Mark
NADiA prosvue prostate-specific antigen slope is an independent prognostic marker for identifying men at reduced risk of clinical recurrence of prostate cancer after radical prostatectomy
(
- Contribution to journal › Article
-
Mark
Predicting prostate cancer many years before diagnosis : How and why?
(
- Contribution to journal › Article
-
Mark
Screening for prostate cancer : To the editor
(
- Contribution to journal › Letter
-
Mark
We need a better marker for prostate cancer. How about renaming PSA?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Urological cancer : Time for another rethink on prostate cancer screening
(
- Contribution to journal › Article
-
Mark
Acoustop horesis pre-alignment of cells enables labelfree enrichment of prostate cancer cells in blood
2012) 16th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2012 In Proceedings of the 16th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2012 p.1696-1698(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2011
-
Mark
Immunoassay for the discrimination of free prostate-specific antigen (fPSA) forms with internal cleavages at Lys(145) or Lys(146) from fPSA without internal cleavages at Lys(145) or Lys(146)
(
- Contribution to journal › Article